CooperCompanies stock gains as activist JANA pushes for CEO change after guidance cut

Published on 09/19/2026 at 21:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CooperCompanies stock moved higher on September 18, 2026 after activist investor JANA Partners called for a CEO change and strategic review. The move followed fiscal Q3 2026 results where revenue of about USD 1.07 billion came in below consensus and guidance was cut.

Reinraum-Produktionsanlage für medizinische Geräte mit Technikern an Kontaktlinsen-Fertigungslinien — CooperCompanies Reinraum-Produktion US21664P1039 zeigt automatisierte Kontaktlinsen-Fertigungslinien mit optischer Qualitätsprüfung im sterilen Reinraumbereich, Illustration mit AI erstellt.

CooperCompanies stock (ISIN US21664P1039) recovered part of its recent losses around mid-September 2026, trading in the mid-USD 50 range on Nasdaq after activist investor JANA Partners pressed the board for a CEO change and strategic options following a guidance cut on fiscal Q3 2026 results reported on September 9, 2026, according to Ad-hoc-news.

Activist campaign follows weaker Q3 2026 figures

The activist pressure from JANA Partners comes shortly after CooperCompanies reported fiscal Q3 2026 revenue of approximately USD 1.07 billion, which was below consensus estimates of roughly USD 1.10 billion for the quarter, as cited by Ad-hoc-news.

According to the same report, the gap of about USD 0.03 billion versus expectations and the associated guidance cut triggered a sharp reaction in the market: CooperCompanies shares fell about 14.7 percent following the earnings release and guidance update on September 9, 2026, reflecting investor concern over weaker-than-expected revenue and a reduced outlook, based on figures compiled from Finance Yahoo and summarized by Ad-hoc-news.

JANA seeks CEO change and asset review

As reported by Ad-hoc-news, activist investor JANA Partners publicly urged CooperCompanies' board in mid-September 2026 to initiate an external search for a new CEO and to evaluate a range of strategic options, including potential asset sales, with the aim of unlocking additional value for shareholders.

The JANA letter, made public around September 18, 2026, argued that the recent revenue miss and guidance reduction underscore structural issues in performance and capital allocation, and that a refreshed leadership team and a sharper portfolio focus could support margin improvement and more consistent growth, according to the summary of JANA's demands in the Ad-hoc-news article.

Share price reaction and current levels

Following the publication of JANA Partners' activist letter, CooperCompanies stock moved higher, with shares up about 3.02 percent at USD 55.40 at the time of publication on September 18, 2026, according to figures cited from NewsBreak and Benzinga and summarized by Ad-hoc-news.

Pre-market trading on the same date was reported at around USD 54.10, about 0.60 percent above the prior close, after CooperCompanies shares had ended the previous regular session 1.53 percent lower, according to RTTNews data referenced in the Ad-hoc-news article.

Next earnings date and investor focus

Looking ahead, investors are watching CooperCompanies' next earnings release. According to Zacks on September 19, 2026, the next earnings release for The Cooper Companies (ticker COO) is expected on December 3, 2026, with a consensus forecast of USD 1.11 earnings per share, implying a year-over-year decrease of 3.48 percent compared with the prior-year quarter.

For the last reported quarter in the Zacks overview, The Cooper Companies delivered earnings of USD 1.15 per share against a consensus estimate of USD 1.11 per share, representing a positive earnings surprise of 3.60 percent for that period, according to Zacks.

Stock remains volatile after Q3 selloff

CooperCompanies stock is listed on Nasdaq in USD with the ticker COO and is a constituent of the S&P 500 index, placing it among the larger health care names in the US market, according to the stock facts cited in Ad-hoc-news.

With the shares having fallen by about 14.7 percent on September 9, 2026 in reaction to the fiscal Q3 2026 guidance cut and revenue miss, and then gaining roughly 3.02 percent to USD 55.40 on September 18, 2026 after the JANA Partners letter, the stock has shown pronounced volatility over a short period, highlighting how earnings surprises, guidance changes and activist involvement can quickly reshape sentiment for a medical devices issuer such as CooperCompanies, according to the trading patterns described by Ad-hoc-news.

CooperCompanies stock price and key data

As of the latest completed trading day referenced in mid-September 2026, CooperCompanies stock traded around USD 55 on Nasdaq, with intraday and pre-market moves between approximately USD 54.10 and USD 55.40 on September 18, 2026 in response to both the prior Q3 2026 selloff and the subsequent rebound linked to JANA's activist campaign.